Axogen AXGN
NASDAQ AXGN
$47.27 +0.58 (+1.24%)
As of: Sep 9, 2026 · 3:59 PM EDT

Axogen (AXGN) Cash from Financing Activities (2010 - 2026)

Axogen (AXGN) posted Cash from Financing Activities of $4.2 million for Q2 2026, down 92.95% on a QoQ basis from $59.5 million in Q1 2026, and up 262.75% year-over-year from $1.2 million in Q2 2025.

Analysis

Axogen (AXGN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Axogen has reported Cash from Financing Activities for 17 years, with the latest figure at $4.2 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 262.75% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $70.7 million, a 1290.71% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 358.47% from the prior year.
  • Cash from Financing Activities was $4.2 million for Q2 2026 at Axogen, down from $59.5 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $59.5 million in Q1 2026, with the low at $5000.0 in Q3 2023.
  • Average Cash from Financing Activities over 5 years is $4.5 million, with a median of $742000.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities sank 97.67% in 2023, then soared 11340.0% in 2024.
  • Over 5 years, Cash from Financing Activities stood at $813000.0 in 2022, then plunged by 48.59% to $418000.0 in 2023, then jumped by 132.06% to $970000.0 in 2024, then surged by 370.72% to $4.6 million in 2025, then decreased by 8.08% to $4.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at $4.2 million (Q2 2026), $59.5 million (Q1 2026), and $4.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -287.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -343.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -300,000.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -607.30 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -213.50 Mn
10 Axogen 2.59 Bn 2.48 Bn 50.67 Mn 4.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.20 Mn
Mar 31, 2026 59.51 Mn
Dec 31, 2025 4.57 Mn
Sep 30, 2025 2.39 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 2.38 Mn
Dec 31, 2024 970,000.00
Sep 30, 2024 572,000.00
Jun 30, 2024 544,000.00
Mar 31, 2024 204,000.00
Dec 31, 2023 418,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 898,000.00
Mar 31, 2023 633,000.00
Dec 31, 2022 813,000.00
Sep 30, 2022 215,000.00
Jun 30, 2022 671,000.00
Mar 31, 2022 95,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 805,000.00